Welcome to the MDI website. Content and updating of information is ongoing on our website, therefore if you cannot find what you are looking for please contact us.
Updated Frequently Asked Questions about coronavirus (Covid-19) and neurological disease from Adult Neurology Services
February 4th, 2021
Updated Frequently Asked Questions about coronavirus (Covid-19) and neurological disease from Adult Neurology Services
MDI wishes to share with you updated Frequently Asked Questions (FAQs) concerning COVID-19 and vaccination from Adult Neurology Services. MDI notes that the FAQs from Adult Neurology Services state that people with chronic neurological conditions such as Muscular Dystrophy, Spinal Muscular Atrophy are considered by the HSE as a ‘vulnerable’ group. However, the HSE information on people who are ‘very high risk’ and ‘high risk’ does not specifically mention people with muscular dystrophy and spinal muscular atrophy but it does list specific health issues that a person may have that qualifies them as ‘very high risk’ or ‘high risk’. You can read the FAQs here.
Categories: Covid-19 • Information
